Correlation Between CVS HEALTH and NeuPath Health
Can any of the company-specific risk be diversified away by investing in both CVS HEALTH and NeuPath Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CVS HEALTH and NeuPath Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CVS HEALTH CDR and NeuPath Health, you can compare the effects of market volatilities on CVS HEALTH and NeuPath Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CVS HEALTH with a short position of NeuPath Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of CVS HEALTH and NeuPath Health.
Diversification Opportunities for CVS HEALTH and NeuPath Health
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between CVS and NeuPath is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding CVS HEALTH CDR and NeuPath Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuPath Health and CVS HEALTH is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CVS HEALTH CDR are associated (or correlated) with NeuPath Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuPath Health has no effect on the direction of CVS HEALTH i.e., CVS HEALTH and NeuPath Health go up and down completely randomly.
Pair Corralation between CVS HEALTH and NeuPath Health
Assuming the 90 days trading horizon CVS HEALTH CDR is expected to under-perform the NeuPath Health. But the stock apears to be less risky and, when comparing its historical volatility, CVS HEALTH CDR is 2.29 times less risky than NeuPath Health. The stock trades about -0.03 of its potential returns per unit of risk. The NeuPath Health is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 17.00 in NeuPath Health on October 12, 2024 and sell it today you would earn a total of 5.00 from holding NeuPath Health or generate 29.41% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
CVS HEALTH CDR vs. NeuPath Health
Performance |
| Timeline |
| CVS HEALTH CDR |
| NeuPath Health |
CVS HEALTH and NeuPath Health Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CVS HEALTH and NeuPath Health
The main advantage of trading using opposite CVS HEALTH and NeuPath Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CVS HEALTH position performs unexpectedly, NeuPath Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuPath Health will offset losses from the drop in NeuPath Health's long position.| CVS HEALTH vs. Canso Select Opportunities | CVS HEALTH vs. Vizsla Silver Corp | CVS HEALTH vs. Maple Peak Investments | CVS HEALTH vs. CVW CleanTech |
| NeuPath Health vs. Medical Facilities | NeuPath Health vs. XXIX Metal Corp | NeuPath Health vs. Osisko Metals | NeuPath Health vs. Partners Value Investments |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |